Lung Cancer News and Research

RSS
Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).
Macrophages likely to be a potential target for ER+ breast cancer

Macrophages likely to be a potential target for ER+ breast cancer

Immune landscape in invasive ER+ breast cancers reveals a macrophage-driven microenvironment

Immune landscape in invasive ER+ breast cancers reveals a macrophage-driven microenvironment

Neoadjuvant dual immunotherapy and chemotherapy improve outcomes in patients with resectable NSCLC

Neoadjuvant dual immunotherapy and chemotherapy improve outcomes in patients with resectable NSCLC

Potential approach to improve solid tumor T cell therapy

Potential approach to improve solid tumor T cell therapy

Using PET and electron microscopy to generate 3D maps of mitochondrial networks in lung tumors

Using PET and electron microscopy to generate 3D maps of mitochondrial networks in lung tumors

New center offers electron microscope services to the scientific community

New center offers electron microscope services to the scientific community

Strata Oncology publishes study validating integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

Strata Oncology publishes study validating integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

Study sheds light on why lung tumors do not respond well to immunotherapy

Study sheds light on why lung tumors do not respond well to immunotherapy

A high-throughput drug discovery assay for the endoplasmic reticulum aminopeptidase 1

A high-throughput drug discovery assay for the endoplasmic reticulum aminopeptidase 1

Novel adoptive T cell receptor therapy shows promising results for patients with solid tumors

Novel adoptive T cell receptor therapy shows promising results for patients with solid tumors

Persistent tumor mutation load may help predict outcome of novel immunotherapies

Persistent tumor mutation load may help predict outcome of novel immunotherapies

New gene helps drive the development of the common lung cancer type

New gene helps drive the development of the common lung cancer type

NIH funds research on mRNA vaccines to stop cancer development

NIH funds research on mRNA vaccines to stop cancer development

Lung cancer treatment with protein insights

Lung cancer treatment with protein insights

Encouraging breakthroughs in eliminating therapy-resistant cancer cells

Encouraging breakthroughs in eliminating therapy-resistant cancer cells

Researchers analyze the significance of cellular interactions for lung cancer

Researchers analyze the significance of cellular interactions for lung cancer

Researchers analyze the involvement of immune cells in lung cancer survival

Researchers analyze the involvement of immune cells in lung cancer survival

Researchers created ultrasound-guided microbubbles to enhance immunotherapy performance

Researchers created ultrasound-guided microbubbles to enhance immunotherapy performance

Cancer biomarkers relying on methylation could forecast tumor type

Cancer biomarkers relying on methylation could forecast tumor type

Study shows how potential target helps to treat lung disease induced by air pollution

Study shows how potential target helps to treat lung disease induced by air pollution

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.